Results
|
|
61.
|
|
|
|
62.
|
|
|
|
63.
|
miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. [electronic resource] by
- Holleman, A
- Chung, I
- Olsen, R R
- Kwak, B
- Mizokami, A
- Saijo, N
- Parissenti, A
- Duan, Z
- Voest, E E
- Zetter, B R
Producer: 20120104
In:
Oncogene vol. 30
Availability: No items available.
|
|
|
64.
|
|
|
|
65.
|
|
|
|
66.
|
|
|
|
67.
|
|
|
|
68.
|
|
|
|
69.
|
|
|
|
70.
|
|
|
|
71.
|
|
|
|
72.
|
|
|
|
73.
|
|
|
|
74.
|
|
|
|
75.
|
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer. [electronic resource] by
- Punt, C J
- Voest, E E
- Tueni, E
- Van Oosterom, A T
- Backx, A
- De Mulder, P H
- Hecquet, B
- Lucas, C
- Gerard, B
- Bleiberg, H
Producer: 19971204
In:
British journal of cancer vol. 76
Availability: No items available.
|
|
|
76.
|
|
|
|
77.
|
|
|
|
78.
|
Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors. [electronic resource] by
- Oostendorp, R L
- Witteveen, P O
- Schwartz, B
- Vainchtein, L D
- Schot, M
- Nol, A
- Rosing, H
- Beijnen, J H
- Voest, E E
- Schellens, J H M
Producer: 20100629
In:
Investigational new drugs vol. 28
Availability: No items available.
|
|
|
79.
|
|
|
|
80.
|
Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors. [electronic resource] by
- Boss, D S
- Witteveen, P O
- van der Sar, J
- Lolkema, M P
- Voest, E E
- Stockman, P K
- Ataman, O
- Wilson, D
- Das, S
- Schellens, J H
Producer: 20110502
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|